4//SEC Filing
DeMuth Peter 4
Accession 0001601485-25-000130
CIK 0001601485other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:05 PM ET
Size
6.9 KB
Accession
0001601485-25-000130
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$4.41/sh+362$1,596→ 743 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-09−362→ 0 totalExercise: $4.41Exp: 2025-12-10→ Common Stock (362 underlying)
Footnotes (1)
- [F1]The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 10, 2016, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001979163
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:05 PM ET
- Size
- 6.9 KB